Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.

by Betticher, D. C., Heighway, J., Thatcher, N., Hasleton, P. S.
Published 1997

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.

by Betticher, D. C., Anderson, H., Ranson, M., Meely, K., Oster, W., Thatcher, N.
Published 1995

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

by Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D., Cerny, T., Thatcher, N.
Published 1996

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies

by Laurencet, F M, Zulian, G B, Guetty-Alberto, M, Iten, P A, Betticher, D C, Alberto, P
Published 1999

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

by Smith, S L, Gugger, M, Hoban, P, Ratschiller, D, Watson, S G, Field, J K, Betticher, D C, Heighway, J
Published 2004

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

by Vonlanthen, S, Heighway, J, Altermatt, H J, Gugger, M, Kappeler, A, Borner, M M, Lohuizen, M van, Betticher, D C
Published 2001

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instabili...

by Smith, S L, Bowers, N L, Betticher, D C, Gautschi, O, Ratschiller, D, Hoban, P R, Booton, R, Santibáñez-Koref, M F, Heighway, J
Published 2005

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer

by Borner, M M, Brousset, P, Pfanner-Meyer, B, Bacchi, M, Vonlanthen, S, Hotz, M A, Altermatt, H J, Schlaifer, D, Reed, J C, Betticher, D C
Published 1999

High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.

by White, G. R., Stack, M., Santibáñez-Koref, M., Liscia, D. S., Venesio, T., Wang, J. C., Helms, C., Donis-Keller, H., Betticher, D. C., Altermatt, H. J., Hoban, P. R., Heighway, J.
Published 1996

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

by Betticher, D C, Hsu Schmitz, S-F, Tötsch, M, Hansen, E, Joss, C, von Briel, C, Schmid, R A, Pless, M, Habicht, J, Roth, A D, Spiliopoulos, A, Stahel, R, Weder, W, Stupp, R, Egli, F, Furrer, M, Honegger, H, Wernli, M, Cerny, T, Ris, H-B
Published 2006